New drug aims to free patients from steroid dependence
NCT ID NCT07156175
Summary
This study is testing an investigational drug called SAR444336 to see if it can help adults with microscopic colitis stay in remission without needing to keep taking steroid medication. Participants must already be in remission while taking budesonide. The main goal is to see if the new drug can help them stay well for 24 weeks after stopping steroids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROSCOPIC COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, S.C. Gastroenterologia U., Investigational Site Number : 380002
RECRUITINGTurin, Torino, 10126, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Azienda Ospedale Università Padova, Investigational Site Number : 380001
RECRUITINGPadua, Padova, 35128, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Investigational Site Number : 380004
RECRUITINGMilan, Milano, 20122, Italy
Contact Email: •••••@•••••
Contact
-
Fondazione Policlinico Gemelli IRCCS Roma, Investigational Site Number : 380003
RECRUITINGRome, Roma, 00168, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Investigational Site Number : 0560001
RECRUITINGLeuven, 3000, Belgium
-
Investigational Site Number : 0560002
RECRUITINGGhent, 9000, Belgium
-
Investigational Site Number : 2080002
RECRUITINGHvidovre, 2650, Denmark
-
Investigational Site Number : 2080003
RECRUITINGAarhus, 8200, Denmark
-
Investigational Site Number : 2500001
RECRUITINGCréteil, 94010, France
-
Investigational Site Number : 2500002
RECRUITINGMontfermeil, 93370, France
-
Investigational Site Number : 2500003
RECRUITINGPessac, 33604, France
-
Investigational Site Number : 2760001
RECRUITINGFrankfurt, 60389, Germany
-
Investigational Site Number : 2760002
RECRUITINGPotsdam, 14467, Germany
-
Investigational Site Number : 2760003
RECRUITINGTübingen, 72076, Germany
-
Investigational Site Number : 2760004
RECRUITINGUlm, 89081, Germany
-
Investigational Site Number : 2760005
RECRUITINGLudwigshafen, 67067, Germany
-
Investigational Site Number : 3480002
RECRUITINGBudapest, 1085, Hungary
-
Investigational Site Number : 3480003
RECRUITINGSzékesfehérvár, 8000, Hungary
-
Investigational Site Number : 6160002
RECRUITINGWarsaw, Masovian Voivodeship, 02-507, Poland
-
Investigational Site Number : 6160003
RECRUITINGWarsaw, Masovian Voivodeship, 00-728, Poland
-
Investigational Site Number : 6160004
RECRUITINGBydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-229, Poland
-
Investigational Site Number : 7520001
RECRUITINGLinköping, 581 85, Sweden
-
Investigational Site Number : 7520002
RECRUITINGStockholm, 113 61, Sweden
-
Investigational Site Number : 7520003
RECRUITINGStockholm, 116 91, Sweden
-
Investigational Site Number : 8260001
RECRUITINGOxford, Oxfordshire, OX3 9DU, United Kingdom
-
Investigational Site Number : 8260002
RECRUITINGCambridge, Cambridgeshire, CB2 2QQ, United Kingdom
Conditions
Explore the condition pages connected to this study.